|
Valeant Pharmaceuticals to Hold Conference Call to Announce 2011 Financial Guidance
|
12/21/10
|
Valeant Pharmaceuticals to Hold Conference Call to Announce 2011 Financial Guidance
|
PDF
|
|
Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
|
12/20/10
|
Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
|
PDF
|
|
Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
|
12/13/10
|
Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
|
PDF
|
|
GSK and Valeant announce receipt of U.S. FDA Complete Response letter for ezogabine
|
12/01/10
|
GSK and Valeant announce receipt of U.S. FDA Complete Response letter for ezogabine
|
PDF
|
|
Valeant Pharmaceuticals to Present At Piper Jeffray 22nd Annual Health Care Conference
|
11/23/10
|
Valeant Pharmaceuticals to Present At Piper Jeffray 22nd Annual Health Care Conference
|
PDF
|
|
Valeant Launches Senior Notes Offering
|
11/18/10
|
Valeant Launches Senior Notes Offering
|
PDF
|
|
Valeant Announces Pricing of Senior Notes
|
11/18/10
|
Valeant Announces Pricing of Senior Notes
|
PDF
|
|
Valeant Pharmaceuticals and S.A.C Capital Settle Lawsuit
|
11/04/10
|
Valeant Pharmaceuticals and S.A.C Capital Settle Lawsuit
|
PDF
|
|
Valeant Announces A $1.5 Billion Securities Repurchase Program
|
11/04/10
|
Valeant Announces A $1.5 Billion Securities Repurchase Program
|
PDF
|
|
Valeant Pharmaceuticals to Gradient Analytics Settle Lawsuit
|
11/04/10
|
Valeant Pharmaceuticals to Gradient Analytics Settle Lawsuit
|
PDF
|
|
Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
|
11/04/10
|
Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
|
PDF
|
|
Valeant Pharmaceuticals and Kadmon Announce Strategic Agreement for Antiviral Therapeutics
|
11/01/10
|
Valeant Pharmaceuticals and Kadmon Announce Strategic Agreement for Antiviral Therapeutics
|
PDF
|
|
Valeant Pharmaceuticals to Acquire #2 Suncare Brand in Australia
|
10/29/10
|
Valeant Pharmaceuticals to Acquire #2 Suncare Brand in Australia
|
PDF
|
|
Valeant Pharmaceuticals to Announce 2010 Third Quarter results on November 4, 2010
|
10/25/10
|
Valeant Pharmaceuticals to Announce 2010 Third Quarter results on November 4, 2010
|
PDF
|
|
Valeant Pharmaceuticals Announces that Alexza Pharmaceuticals Has Received A Complete Response Letter For AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
|
10/11/10
|
Valeant Pharmaceuticals Announces that Alexza Pharmaceuticals Has Received A Complete Response Letter For AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
|
PDF
|
|
Valeant and Biovail Complete Merger
|
09/28/10
|
Valeant and Biovail Complete Merger
|
PDF
|
|
Valeant and Biovail Announce Results of Special Meetings of Shareholders
|
09/27/10
|
Valeant and Biovail Announce Results of Special Meetings of Shareholders
|
PDF
|
|
Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
|
09/27/10
|
Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
|
PDF
|
|
Valeant and Biovail Announce Valeant's Intention to Declare a Special Dividend to Valeant Stockholders upon Obtaining Shareholder Approval, Financing and Satisfaction of Other Closing Conditions
|
09/22/10
|
Valeant and Biovail Announce Valeant's Intention to Declare a Special Dividend to Valeant Stockholders upon Obtaining Shareholder Approval, Financing and Satisfaction of Other Closing Conditions
|
PDF
|
|
Valeant Announces Pricing of Senior Notes
|
09/22/10
|
Valeant Announces Pricing of Senior Notes
|
PDF
|
|
Valeant Plans Senior Notes Offering and Begins Arrangement of New Credit Facilities
|
09/09/10
|
Valeant Plans Senior Notes Offering and Begins Arrangement of New Credit Facilities
|
PDF
|
|
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
|
08/30/10
|
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
|
PDF
|
|
Valeant and Biovail Set Date for Shareholders Meetings
|
08/11/10
|
Valeant and Biovail Set Date for Shareholders Meetings
|
PDF
|
|
Ezogabine, an Investigational Anti-Epileptic Drug, Receives Positive Vote from FDA Advisory Committee
|
08/11/10
|
Ezogabine, an Investigational Anti-Epileptic Drug, Receives Positive Vote from FDA Advisory Committee
|
PDF
|
|
Biovail Reports Second-Quarter 2010 Financial Results
|
08/05/10
|
Biovail Reports Second-Quarter 2010 Financial Results
|
PDF
|
|
Biovail Declares Quarterly Dividend
|
08/05/10
|
Biovail Declares Quarterly Dividend
|
PDF
|
|
Valeant Pharmaceuticals Reports 2010 Second Quarter Financial Results
|
08/02/10
|
Valeant Pharmaceuticals Reports 2010 Second Quarter Financial Results
|
PDF
|
|
Biovail Announces Second-Quarter 2010 Earnings Release, Conference-Call Details
|
07/23/10
|
Biovail Announces Second-Quarter 2010 Earnings Release, Conference-Call Details
|
PDF
|
|
Valeant Pharmaceuticals to Announce 2010 Second Quarter Results on August 2, 2010
|
07/22/10
|
Valeant Pharmaceuticals to Announce 2010 Second Quarter Results on August 2, 2010
|
PDF
|
|
Valeant Pharmaceuticals Resumes Shipment of Oxsoralen-Ultra(R)
|
06/23/10
|
Valeant Pharmaceuticals Resumes Shipment of Oxsoralen-Ultra(R)
|
PDF
|
|
Biovail and MedGenesis Announce Grant from The Michael J. Fox Foundation for the Development of GDNF
|
06/22/10
|
Biovail and MedGenesis Announce Grant from The Michael J. Fox Foundation for the Development of GDNF
|
PDF
|
|
Valeant and Biovail Agree to Merge
|
06/21/10
|
Valeant and Biovail Agree to Merge
|
PDF
|
|
Valeant and Biovail Agree to Merge
|
06/21/10
|
Valeant and Biovail Agree to Merge
|
PDF
|
|
Biovail Enters into License Agreement with Kyowa Hakko Kirin
|
06/03/10
|
Biovail Enters into License Agreement with Kyowa Hakko Kirin
|
PDF
|
|
Valeant Pharmaceuticals to Host Investor Day
|
06/03/10
|
Valeant Pharmaceuticals to Host Investor Day
|
PDF
|
|
Valeant Pharmaceuticals Completes Acquisition of Aton Pharma, Inc.
|
05/27/10
|
Valeant Pharmaceuticals Completes Acquisition of Aton Pharma, Inc.
|
PDF
|
|
Valeant Pharmaceuticals Announces Regulatory Approval of Onsolis(TM) in Canada
|
05/10/10
|
Valeant Pharmaceuticals Announces Regulatory Approval of Onsolis(TM) in Canada
|
PDF
|
|
Biovail Reports First-Quarter 2010 Financial Results
|
05/06/10
|
Biovail Reports First-Quarter 2010 Financial Results
|
PDF
|
|
Biovail Announces Increase to Quarterly Dividend
|
05/06/10
|
Biovail Announces Increase to Quarterly Dividend
|
PDF
|
|
Valeant Pharmaceuticals to Webcast 2010 Annual Meeting of Stockholders
|
05/04/10
|
Valeant Pharmaceuticals to Webcast 2010 Annual Meeting of Stockholders
|
PDF
|
|
Valeant Pharmaceuticals Reports 2010 First Quarter Financial Results
|
05/03/10
|
Valeant Pharmaceuticals Reports 2010 First Quarter Financial Results
|
PDF
|
|
Valeant to Acquire Vital Science Corp. in Canada
|
04/28/10
|
Valeant to Acquire Vital Science Corp. in Canada
|
PDF
|
|
Valeant Pharmaceuticals to Announce 2010 First Quarter Results on May 3, 2010
|
04/23/10
|
Valeant Pharmaceuticals to Announce 2010 First Quarter Results on May 3, 2010
|
PDF
|
|
Biovail Announces First-Quarter 2010 Earnings Release, Conference-Call Details
|
04/22/10
|
Biovail Announces First-Quarter 2010 Earnings Release, Conference-Call Details
|
PDF
|
|
Valeant to Acquire Pharmaceutical Company in Brazil
|
04/21/10
|
Valeant to Acquire Pharmaceutical Company in Brazil
|
PDF
|
|
Valeant Pharmaceuticals Announces Pricing of Senior Notes
|
04/07/10
|
Valeant Pharmaceuticals Announces Pricing of Senior Notes
|
PDF
|
|
Valeant Plans Senior Notes Offering
|
04/06/10
|
Valeant Plans Senior Notes Offering
|
PDF
|
|
Valeant Announces Increase to Securities Repurchase Program
|
03/30/10
|
Valeant Announces Increase to Securities Repurchase Program
|
PDF
|
|
Biovail Acquires AMPAKINE(R) Compounds for Treatment of Respiratory Depression
|
03/26/10
|
Biovail Acquires AMPAKINE(R) Compounds for Treatment of Respiratory Depression
|
PDF
|
|
Valeant to Acquire Branded Generics/OTC Company in Brazil
|
03/19/10
|
Valeant to Acquire Branded Generics/OTC Company in Brazil
|
PDF
|
|
Valeant Pharmaceuticals Announces Annual Stockholder Meeting Date
|
03/18/10
|
Valeant Pharmaceuticals Announces Annual Stockholder Meeting Date
|
PDF
|
|
Valeant Pharmaceuticals to Present at Cowen and Company 30th Annual Health Care Conference
|
03/02/10
|
Valeant Pharmaceuticals to Present at Cowen and Company 30th Annual Health Care Conference
|
PDF
|
|
Valeant Enters Collaboration With Spear Pharmaceuticals
|
03/01/10
|
Valeant Enters Collaboration With Spear Pharmaceuticals
|
PDF
|
|
Biovail Reports Fourth Quarter, Year-End 2009 Financial Results
|
02/25/10
|
Biovail Reports Fourth Quarter, Year-End 2009 Financial Results
|
PDF
|
|
Biovail Declares Quarterly Dividend
|
02/25/10
|
Biovail Declares Quarterly Dividend
|
PDF
|
|
Valeant Pharmaceuticals Reports 2009 Fourth Quarter and Full Year Financial Results
|
02/22/10
|
Valeant Pharmaceuticals Reports 2009 Fourth Quarter and Full Year Financial Results
|
PDF
|
|
Biovail Comments on Filing of Complaints
|
02/19/10
|
Biovail Comments on Filing of Complaints
|
PDF
|
|
Biovail Announces Fourth-Quarter 2009 Earnings Release, Conference-Call Details
|
02/12/10
|
Biovail Announces Fourth-Quarter 2009 Earnings Release, Conference-Call Details
|
PDF
|
|
Biovail Enters into License and Collaboration Agreement with Alexza for AZ-004
|
02/10/10
|
Biovail Enters into License and Collaboration Agreement with Alexza for AZ-004
|
PDF
|
|
Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010
|
02/08/10
|
Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010
|
PDF
|
|
Biovail Comments on Proposed Generic Wellbutrin XL(R) Trial
|
01/22/10
|
Biovail Comments on Proposed Generic Wellbutrin XL(R) Trial
|
PDF
|
|
Biovail to Present at JPMorgan Healthcare Conference
|
01/06/10
|
Biovail to Present at JPMorgan Healthcare Conference
|
PDF
|
|
Valeant Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
|
01/06/10
|
Valeant Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
|
PDF
|
|
Valeant Pharmaceuticals to Hold Conference Call to Announce 2010 Financial Guidance
|
01/05/10
|
Valeant Pharmaceuticals to Hold Conference Call to Announce 2010 Financial Guidance
|
PDF
|
